ACP Video Intervention for Life-Limiting Illness
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help people with serious illnesses learn more about planning for future medical care and hospice options. Participants will either continue with their usual care or receive a special visit from a clinician who will show them a video about advance care planning (ACP) and answer any questions. This trial suits those who have been told they likely have a year or less to live and speak one of the languages available in the video. As an unphased trial, this study offers a unique opportunity to gain valuable insights into planning for future care and making informed decisions.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this video intervention is safe for patients with serious illness?
Research shows that using videos for advance care planning (ACP) is generally safe. Studies have examined ACP videos designed to inform patients about their end-of-life care options. These videos help patients communicate their wishes to doctors and increase the documentation of these wishes. No reports indicate negative effects from watching these videos. As an educational tool rather than a medical treatment, the video is considered very low risk.12345
Why are researchers excited about this trial?
Researchers are excited about the ACP Video Intervention because it offers a unique approach to advance care planning for patients with life-limiting illnesses. Unlike traditional methods that rely on face-to-face conversations or written materials, this intervention uses a video format that can be accessed at home. This method provides a more engaging and easily digestible way for patients to understand their care options and make informed decisions. Additionally, having a trained clinician discuss the video content and answer questions enhances patient understanding and comfort, which might lead to better patient outcomes and satisfaction.
What evidence suggests that the ACP Video Intervention is effective for increasing knowledge about advance care planning?
Research has shown that using a video for advance care planning (ACP) can facilitate communication between patients and doctors. In this trial, participants in the video intervention arm will access the ACP video, which studies have shown helps more people document their end-of-life choices, ensuring their wishes are known and respected. One study found that using videos for ACP was linked to fewer hospital visits at the end of life for those with serious illnesses. Overall, these videos help people understand their options, such as CPR (cardiopulmonary resuscitation) and hospice care, leading to better planning and decision-making.34678
Are You a Good Fit for This Trial?
This trial is for adults over the age of 21 with serious illnesses who are receiving home-based care and have a life expectancy of one year or less, as determined by a specific algorithm. Participants must speak English or any of the other 25 languages available for the video intervention. It's not suitable for those with significant visual impairment or cognitive issues due to psychiatric illness.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive usual care or usual care plus a visit by a trained study clinician to provide access to the ACP video and discuss its content
Follow-up
Participants are monitored for outcomes such as knowledge about ACP, documentation rates, and satisfaction with communication
What Are the Treatments Tested in This Trial?
Interventions
- Home ACP Video
Home ACP Video is already approved in United States for the following indications:
- Life-limiting illnesses
- Serious illnesses requiring home-based care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor